DNA CONTENT MODULATION BY HPR IN BLADDER TUMORS
DNA CONTENT MODULATION BY HPR IN BLADDER TUMORS
批准号:
2097321
负责人:
ANDREA U DECENSI
金额:
$10.02万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-08-01 至 1997-07-31
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
The synthetic retinoid fenretinide lowers plasma insulin-like growth factor I levels in breast cancer patients.
合成类视黄醇芬维A胺可降低乳腺癌患者血浆胰岛素样生长因子 I 水平。
DOI:
--
发表时间:
1993
期刊:
Cancer research
影响因子:
11.2
作者:
[Torrisi,R, Pensa,F, Orengo,MA, Catsafados,E, Ponzani,P, Boccardo,F, Costa,A, Decensi,A]
通讯作者:
Decensi,A
Ocular effects of fenretinide, a vitamin A analog, in a chemoprevention trial of bladder cancer.
芬维A胺(一种维生素 A 类似物)在膀胱癌化学预防试验中的眼部作用。
DOI:
--
发表时间:
2000
期刊:
Cancer detection and prevention.
影响因子:
--
作者:
[Baglietto,L, Torrisi,R, Arena,G, Tosetti,F, Gonzaga,AG, Pasquetti,W, Robertson,C, Decensi,A]
通讯作者:
Decensi,A
Factors affecting plasma retinol decline during long-term administration of the synthetic retinoid fenretinide in breast cancer patients.
乳腺癌患者长期服用合成类维生素A芬维A胺期间影响血浆视黄醇下降的因素。
DOI:
--
发表时间:
1994
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
作者:
[Torrisi,R, Parodi,S, Fontana,V, Rondanina,G, Formelli,F, Costa,A, Boccardo,F, Decensi,A]
通讯作者:
Decensi,A
Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point.
使用 DNA 流式细胞术作为中间终点的芬维A胺治疗浅表性膀胱癌的随机试验。
DOI:
--
发表时间:
2000
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
影响因子:
--
作者:
[Decensi,A, Torrisi,R, Bruno,S, Costantini,M, Curotto,A, Nicolo,G, Malcangi,B, Baglietto,L, Bruttini,GP, Gatteschi,B, Rondanina,G, Varaldo,M, Perloff,M, Malone,WF, Bruzzi,P]
通讯作者:
Bruzzi,P
Effect of the synthetic retinoid fenretinide on circulating free prostate-specific antigen, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 levels in men with superficial bladder cancer.
合成类视黄醇芬维A胺对浅表性膀胱癌男性循环游离前列腺特异性抗原、胰岛素样生长因子-I 和胰岛素样生长因子结合蛋白-3 水平的影响。
DOI:
10.1158/1078-0432.ccr-04-1549
发表时间:
2005
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research.
影响因子:
--
作者:
[Serrano,Davide, Baglietto,Laura, Johansson,Harriet, Mariette,Frederique, Torrisi,Rosalba, Onetto,Marina, Paganuzzi,Michela, Decensi,Andrea]
通讯作者:
Decensi,Andrea
共 6 条
LOW DOSE TAMOXIFEN AND 4HPR IN EARLY BREAST CANCER
-
批准号:2896377
-
项目类别:
-
资助金额:$34.41万
-
财政年份:1997
-
负责人:ANDREA U DECENSI
-
依托单位:
LOW DOSE TAMOXIFEN AND 4HPR IN EARLY BREAST CANCER
-
批准号:6173193
-
项目类别:
-
资助金额:$35.44万
-
财政年份:1997
-
负责人:ANDREA U DECENSI
-
依托单位:
LOW DOSE TAMOXIFEN AND 4HPR IN EARLY BREAST CANCER
-
批准号:2558517
-
项目类别:
-
资助金额:$32.44万
-
财政年份:1997
-
负责人:ANDREA U DECENSI
-
依托单位:
LOW DOSE TAMOXIFEN AND 4HPR IN EARLY BREAST CANCER
-
批准号:2769994
-
项目类别:
-
资助金额:$33.41万
-
财政年份:1997
-
负责人:ANDREA U DECENSI
-
依托单位:
DNA CONTENT MODULATION BY HPR IN BLADDER TUMORS
-
批准号:3549833
-
项目类别:
-
资助金额:$9.83万
-
财政年份:1992
-
负责人:ANDREA U DECENSI
-
依托单位:
DNA CONTENT MODULATION BY HPR IN BLADDER TUMORS
-
批准号:3549832
-
项目类别:
-
资助金额:$9.45万
-
财政年份:1992
-
负责人:ANDREA U DECENSI
-
依托单位:
海外基金